| AIAN REVIEW |
|
| Ahead of Print |
|
|
Movement disorder in demyelinating disease: Tracing the charcot's foot print
Rashmi Singh, Sanjay Pandey
Department of Neurology, Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi, India
Correspondence Address:
Sanjay Pandey,
Department of Neurology, Academic Block, Room no 503, Department of Neurology, Govind Ballabh Pant Postgraduate Institute of Medical Education and Research, New Delhi - 110 002
India
 Source of Support: None, Conflict of Interest: None DOI: 10.4103/aian.aian_64_22
|
|
|
Movement disorders may be one of the neurological manifestations of demyelinating disorders. They can manifest in Parkinsonism or a wide spectrum of hyperkinetic movement disorders including tremor, paroxysmal dyskinesia, dystonia, chorea, and ballism. Some of these disorders occur during an acute episode of demyelination, whereas others can develop later or even may precede the onset of the demyelinating disorders. The pathophysiology of movement disorders in demyelination is complex and the current evidence indicates a wide involvement of different brain networks and spinal cord. Treatment is mainly symptomatic and oral pharmacological agents are the mainstay of the management. Botulinum toxin and neurosurgical interventions may be required in selected patients.
|
|
|
|
|
|
|
[NEXT]
